Publication | Open Access

High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group

Surgical OncologyOncologyBone Sarcoma GroupMetronomic TherapyHigh-dose EpirubicinEortc Soft TissuePharmacotherapyMetronomic ChemotherapyCancer TreatmentMedicineRadiation Oncology